- Details
- Written by: Administrator
Roche has announced that phase III clinical studies have been initiated for lampalizumab, an investigational drug for geographic atrophy (GA), the advanced form of age-related macular degeneration (AMD).
- Details
- Written by: Administrator
Roche has announced that phase III clinical studies have been initiated for lampalizumab, an investigational drug for geographic atrophy (GA), the advanced form of age-related macular degeneration (AMD).
- Details
- Written by: Administrator
The research team of Jean Bennett reported a clinical phase 3 study on the efficacy of the RPE65 gene therapy vector.
Continue reading: News on the RPE65 phase-3 Gene Therapy Trials